Civica Rx inks agreement with drug company
Civica Rx announced a five-year agreement this week with London-based Hikma Pharmaceuticals to produce 14 sterile injectable medications for U.S. hospitals that are often in short supply.
To access this content, you must purchase a Premium membership, or log in if you are a member.
